Elanco Animal Health (ELAN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $23.54, +4.39% vs the prior close of $22.55.
- Volume 6.65M shares, 1.0x its 50-day average.
- New SEC filings: 144 (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
ELAN jumps 4.4% to $23.54, a 1-month high. Closed at $23.54, +4.39% vs the prior close of $22.55. Day range $22.80–$23.79, opened at $22.83.
ELAN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ELAN jumps 4.4% to $23.54, a 1-month high
- Closed at $23.54, +4.39% vs the prior close of $22.55. Day range $22.80–$23.79, opened at $22.83.
- Volume was 6.65M shares, 1.0x its 50-day average of 6.44M.
- Price is +1.5% vs its 50-day average ($23.18) and -1.2% vs its 200-day average ($23.82).
- 52-week range $19.40–$27.98; today's close sits at 48% of that range, 15.9% below the 52-week high.
Oct 14, 2026 — ELAN rises 0.6% to $22.55
- Closed at $22.55, +0.62% vs the prior close of $22.41. Day range $22.26–$22.92, opened at $22.38.
- Volume was 4.94M shares, 0.8x its 50-day average of 6.52M.
- Price is -2.9% vs its 50-day average ($23.24) and -5.3% vs its 200-day average ($23.81).
- 52-week range $19.40–$27.98; today's close sits at 37% of that range, 19.4% below the 52-week high.
Oct 13, 2026 — ELAN dips 0.7% to $22.41
- Closed at $22.41, -0.66% vs the prior close of $22.56. Day range $22.22–$22.77, opened at $22.63.
- Volume was 3.35M shares, 0.5x its 50-day average of 6.57M — lighter than usual.
- Price is -3.8% vs its 50-day average ($23.30) and -5.9% vs its 200-day average ($23.81).
- 52-week range $19.40–$27.98; today's close sits at 35% of that range, 19.9% below the 52-week high.
Oct 12, 2026 — ELAN dips 1.6% to $22.56
- Closed at $22.56, -1.57% vs the prior close of $22.92. Day range $22.55–$22.93, opened at $22.88.
- Volume was 4.65M shares, 0.7x its 50-day average of 6.58M.
- Price is -3.4% vs its 50-day average ($23.36) and -5.3% vs its 200-day average ($23.81).
- 52-week range $19.40–$27.98; today's close sits at 37% of that range, 19.4% below the 52-week high.
Oct 9, 2026 — ELAN rises 1.7% to $22.92
- Closed at $22.92, +1.69% vs the prior close of $22.54. Day range $22.42–$22.98, opened at $22.59.
- Volume was 2.52M shares, 0.4x its 50-day average of 6.68M — lighter than usual.
- Price is -2.2% vs its 50-day average ($23.44) and -3.7% vs its 200-day average ($23.81).
- 52-week range $19.40–$27.98; today's close sits at 41% of that range, 18.1% below the 52-week high.
Oct 8, 2026 — ELAN rises 0.8% to $22.54
- Closed at $22.54, +0.81% vs the prior close of $22.36. Day range $22.00–$22.63, opened at $22.08.
- Volume was 4.57M shares, 0.7x its 50-day average of 6.72M.
- Price is -4.1% vs its 50-day average ($23.51) and -5.3% vs its 200-day average ($23.81).
- 52-week range $19.40–$27.98; today's close sits at 37% of that range, 19.4% below the 52-week high.
Oct 7, 2026 — ELAN dips 0.5% to $22.36
- Closed at $22.36, -0.53% vs the prior close of $22.48. Day range $22.16–$22.62, opened at $22.26.
- Volume was 4.20M shares, 0.6x its 50-day average of 6.72M.
- Price is -5.2% vs its 50-day average ($23.59) and -6.1% vs its 200-day average ($23.81).
- 52-week range $19.40–$27.98; today's close sits at 34% of that range, 20.1% below the 52-week high.
Oct 6, 2026 — ELAN ends flat (-0.1%) to $22.48
- Closed at $22.48, -0.13% vs the prior close of $22.51. Day range $22.23–$23.04, opened at $22.72.
- Volume was 7.04M shares, 1.1x its 50-day average of 6.64M.
- Price is -4.9% vs its 50-day average ($23.65) and -5.6% vs its 200-day average ($23.81).
- 52-week range $19.40–$27.98; today's close sits at 36% of that range, 19.7% below the 52-week high.
Oct 5, 2026 — ELAN rises 1.7% to $22.51
- Closed at $22.51, +1.67% vs the prior close of $22.14. Day range $21.72–$22.73, opened at $22.09.
- Volume was 4.79M shares, 0.7x its 50-day average of 6.62M.
- Price is -5.1% vs its 50-day average ($23.71) and -5.4% vs its 200-day average ($23.80).
- 52-week range $19.40–$27.98; today's close sits at 36% of that range, 19.5% below the 52-week high.
Oct 2, 2026 — ELAN rises 1.7% to $22.14
- Closed at $22.14, +1.70% vs the prior close of $21.77. Day range $21.77–$22.36, opened at $22.04.
- Volume was 5.00M shares, 0.8x its 50-day average of 6.64M.
- Price is -6.8% vs its 50-day average ($23.76) and -7.0% vs its 200-day average ($23.80).
- 52-week range $19.40–$27.98; today's close sits at 32% of that range, 20.9% below the 52-week high.
ELAN latest news & SEC filings
Every SEC filing by or about ELAN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 6, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 6, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 6, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 22, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.37B (prior year $1.24B) (+10.2% vs Jun 30, 2025)
- Net income: $54.00M (prior year $11.00M) (+390.9% vs Jun 30, 2025)
- Diluted EPS: $0.11 (prior year $0.02) (+450.0% vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 14, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade ELAN
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 24, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.26% (largest 4.4%).
- Liquidity: about 5.43M shares (≈$127.76M) trade per day on average.
- 52-week position: $23.54 vs a range of $19.40–$27.98 (48% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 11 open-market buys, 0 sales; latest: Lawrence Erik Kurzius bought 40,000 shares on Aug 20, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K May 27, 2026.
- Share count: 499.62M shares outstanding (Aug 3, 2026), +0.6% vs a year earlier.
- Listing: NYSE · industry: Pharmaceutical Preparations.
ELAN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 22.83 | 23.79 | 22.80 | 23.54 | 6.65M |
| Oct 14, 2026 | 22.38 | 22.92 | 22.26 | 22.55 | 4.94M |
| Oct 13, 2026 | 22.63 | 22.77 | 22.22 | 22.41 | 3.35M |
| Oct 12, 2026 | 22.88 | 22.93 | 22.55 | 22.56 | 4.65M |
| Oct 9, 2026 | 22.59 | 22.98 | 22.42 | 22.92 | 2.52M |
| Oct 8, 2026 | 22.08 | 22.63 | 22.00 | 22.54 | 4.57M |
| Oct 7, 2026 | 22.26 | 22.62 | 22.16 | 22.36 | 4.20M |
| Oct 6, 2026 | 22.72 | 23.04 | 22.23 | 22.48 | 7.04M |
| Oct 5, 2026 | 22.09 | 22.73 | 21.72 | 22.51 | 4.79M |
| Oct 2, 2026 | 22.04 | 22.36 | 21.77 | 22.14 | 5.00M |
| Oct 1, 2026 | 22.32 | 22.50 | 21.62 | 21.77 | 5.87M |
| Sep 30, 2026 | 22.60 | 22.86 | 22.35 | 22.39 | 5.36M |
| Sep 29, 2026 | 22.48 | 22.69 | 22.16 | 22.61 | 5.41M |
| Sep 28, 2026 | 22.01 | 22.64 | 21.92 | 22.45 | 6.59M |
| Sep 25, 2026 | 22.35 | 22.72 | 22.10 | 22.31 | 6.45M |
| Sep 24, 2026 | 22.59 | 22.63 | 21.75 | 22.35 | 7.64M |
| Sep 23, 2026 | 22.82 | 23.39 | 22.51 | 22.57 | 5.34M |
| Sep 22, 2026 | 22.53 | 23.18 | 22.51 | 22.93 | 5.61M |
| Sep 21, 2026 | 22.58 | 22.58 | 22.17 | 22.43 | 4.61M |
| Sep 18, 2026 | 22.77 | 22.88 | 22.28 | 22.42 | 7.95M |
About Elanco Animal Health
Elanco Animal Health (ELAN) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in INDIANAPOLIS, IN. Fiscal year ends December 31. SEC CIK 1739104.
ELAN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kapila K Anand | Director | Jul 2, 2026 |
| Art A Garcia | Director | May 26, 2026 |
| R David Hoover | Director | May 26, 2026 |
| Michael J Harrington | Director | Aug 13, 2026 |
| Paul Herendeen | Director | Aug 10, 2026 |
| Deborah Turner Kochevar | Director | May 26, 2026 |
| Lawrence Erik Kurzius | Director | Aug 21, 2026 |
| Stacey Ma | Director | May 26, 2026 |
| Kirk P Mcdonald | Director | May 26, 2026 |
| Denise Scots-Knight | Director | May 26, 2026 |
| Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | Sep 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Timothy J Bettington | SEE REMARKS | Mar 5, 2026 |
| Ramiro Martin Cabral | SEE REMARKS | Mar 5, 2026 |
| De Simas Jose Manuel Correia | SEE REMARKS | Mar 10, 2026 |
| David S Kinard | SEE REMARKS | Jul 2, 2026 |
| Grace Mcardle | EVP, MANUFACTURING AND QUALITY | Mar 5, 2026 |
| James M Meer | CHIEF ACCOUNTING OFFICER | Mar 5, 2026 |
| Rajeev A. Modi | SEE REMARKS | Sep 22, 2026 |
| Shiv O'Neill | GC AND CORP SEC | Aug 18, 2026 |
| Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | Sep 22, 2026 |
| Robert M Vanhimbergen | EVP and CFO | Sep 22, 2026 |
| Brabander Ellen De | SEE REMARKS | Apr 7, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 20, 2026 | Lawrence Erik Kurzius | Buy | 40,000 | $23.40 |
| Aug 18, 2026 | Shiv O'Neill | Buy | 3,998 | $23.58 |
| Aug 12, 2026 | Michael J Harrington | Buy | 5,000 | $21.82 |
| Aug 7, 2026 | Paul Herendeen | Buy | 10,000 | $23.69 |
| Aug 7, 2026 | Robert M Vanhimbergen | Buy | 4,200 | $23.08 |
| May 15, 2026 | Rajeev A. Modi | Buy | 4,911 | $20.35 |
| May 15, 2026 | Jeffrey N Simmons | Buy | 4,971 | $20.09 |
| Dec 12, 2025 | Lawrence Erik Kurzius | Buy | 10,000 | $21.30 |
| Dec 11, 2025 | Rajeev A. Modi | Buy | 4,500 | $21.33 |
| Dec 11, 2025 | Jeffrey N Simmons | Buy | 22,000 | $21.75 |
| Dec 11, 2025 | Robert M Vanhimbergen | Buy | 6,950 | $21.64 |
ELAN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $4.71B | $-232.00M | -0.47 | $560.00M |
| Dec 31, 2024 | $4.44B | $338.00M | 0.68 | $541.00M |
| Dec 31, 2023 | $4.42B | $-1.23B | -2.50 | $271.00M |
| Dec 31, 2022 | $4.41B | $-78.00M | -0.16 | $452.00M |
| Dec 31, 2021 | $4.76B | $-483.00M | -0.99 | $483.00M |
Latest balance sheet: total assets $13.56B, total liabilities $6.97B, cash $530.00M (as of Jun 30, 2026).
ELAN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $26.22 |
| May 6, 2026 | 8-K Item 2.02 (results) | $26.18 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $26.38 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $21.60 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $16.48 |
| May 7, 2025 | 8-K Item 2.02 (results) | $12.01 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $10.70 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $14.50 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Feb 26, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ELAN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.